FDA recall D-1037-2016

Fresenius Kabi USA, LLC · Class II · drug

Product

Sensorcaine- MPF (Bupivacaine HCI Injection, USP), 0.75% in a 30 mL Single Dose Vial, Rx only, Fresenius Kabi USA LLC, Lake Zurich, IL 60047, NDC 63323-472-37

Reason for recall

Presence of Particulate Matter: Glass particulate found in sterile injectable product

Distribution

Nationwide

Key facts

Status
Terminated
Initiation date
2016-04-25
Report date
2016-06-22
Termination date
2016-10-20
Voluntary/Mandated
Voluntary: Firm initiated
Location
Lake Zurich, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1037-2016